reported that metformin (used to treat T2D) upregulated the levels of autophagy to alleviate oxidative stress in renal tissue, and reduced pathological and structural changes of glomeruli through the deacetylation and activation of FOXO1 by SIRT1 (84). The gene discussed is SIRT1; the disease is type 2 diabetes mellitus.